Brief Summary:

The primary objective of this study is to evaluate the efficacy of 2 remdesivir (RDV) regimens with respect to clinical status assessed by a 7-point ordinal scale on Day 14.

Condition or disease Intervention/treatment Phase COVID-19 Drug: Remdesivir Drug: Standard of Care Phase 3

Expanded Access

available

: An investigational treatment associated with this study isoutside the clinical trial. More info ...